Very solid first half result. The company full year guidance looks rather conservative in this light, even factoring in the extra spend on tendering for the $150 million contract.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025